Stakeholder Assessment of the Evidence for Cancer Genomic Tests: Insights from Three Case Studies

Insufficient evidence on the net benefits and harms of genomic tests in real-world settings is a translational barrier for genomic medicine. PURPOSE: Understanding stakeholders’ assessment of the current evidence base for clinical practice and coverage decisions should be a critical step to influenc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genet Med
Main Authors: Deverka, Patricia A., Schully, Sheri D., Ishibe, Naoko, Carlson, Josh J., Freedman, Andrew, Goddard, Katrina A.B., Khoury, Muin J., Ramsey, Scott D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4437504/
https://ncbi.nlm.nih.gov/pubmed/22481130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2012.3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados